Author

Nicolas A. Moyer

Observed name: Nicolas Moyer

Institutions: Christ Hospital, Invitae (United States)

Observed institutions: Christ Hospital, Invitae (United States)

ORCID: 0000-0003-4269-2327

Observed ORCID: 0000-0003-4269-2327

OpenAlex ID: A5002489972

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial

2017 · Lindsay S. Elliott, John C. Henderson, et al. · PLoS ONE · 164

Cytochrome P–450 gene and drug interaction analysis in patients referred for pharmacogenetic testing

2015 · Brian Thomas Hocum, John Raymond White, et al. · American Journal of Health-System Pharmacy · 54

Implementing comprehensive pharmacogenomics in a community hospital–associated primary care setting

2022 · Jennifer A. Wick, Tara Schmidlen, et al. · Journal of the American Pharmacists Association · 19

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population

2022 · Kristine Ashcraft, Kendra Grande, et al. · Journal of Personalized Medicine · 7

Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program

2022 · Kendra J. Grande, Rachel Dalton, et al. · Journal of Personalized Medicine · 5

Works count: 5

Citation count: 249

H-index: 5

I10-index: 3